SCHEMBL21633974

SCHEMBL21633974

CC(C)CCC1(CO)CCCCC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 2/20 0.31
CDC25B P30305 2/20 0.31
CETP P11597 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31311243 0.80
SCHEMBL14858101 0.77 PDE7B (0.31)
SCHEMBL28965369 0.76 ALDH1A1 (0.53)
SCHEMBL28155527 0.75 CETP (0.32) CETP
SCHEMBL8776156 0.75
SCHEMBL10020999 0.75 TSHR (0.32)
SCHEMBL14143534 0.75 USP2 (0.31)
SCHEMBL2485471 0.75 USP2 (0.31)
SCHEMBL1129493 0.74 USP2 (0.33)
Methyl Alcohol SCHEMBL27831139 0.73 ALDH1A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3826986-B1 NOVEL ODORANTS HAVING ROSE ODOUR SYMRISE AG (DE) 2026-03-04 EP disclosed
CN-117986090-A Novel fragrances with rose scent 西姆莱斯股份公司 2024-05-07 CN disclosed
CN-112469685-B Novel fragrances with rose scent 西姆莱斯股份公司 2024-01-02 CN disclosed
US-11634659-B2 Fragrances with rose scent SYMRISE AG (DE) 2023-04-25 US disclosed
US-20210324300-A1 NOVEL FRAGRANCES WITH ROSE SCENT SYMRISE AG (DE) 2021-10-21 US disclosed
EP-3826986-A1 NOVEL ODORANTS HAVING ROSE ODOUR Symrise AG (DE) 2021-06-02 EP disclosed
CN-112469685-A Novel flavoring agent with rose smell 西姆莱斯股份公司 2021-03-09 CN disclosed
WO-2020020434-A1 NOVEL ODORANTS HAVING ROSE ODOUR SYMRISE AG (DE) 2020-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634659-B2 Fragrances with rose scent NR1H2, DUOX2, AOX1 CDC25A 3340/4885CDC25B 3597/4885CETP 271/4885
US-20210324300-A1 NOVEL FRAGRANCES WITH ROSE SCENT NR1H2, DUOX2, AOX1 CDC25A 3448/4885CDC25B 3797/4885CETP 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.